For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
In other words, the price has increased by $0.00 from its previous closing price. On the day, 0.88 million shares were traded. ITRM stock price reached its highest trading level at $0.34 during the session, while it also had its lowest trading level at $0.3105.
On March 15, 2021, H.C. Wainwright Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $2.50.
RBC Capital Mkts Downgraded its Outperform to Sector Perform on June 02, 2020, whereas the target price for the stock was revised from $7 to $2.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 18 ’25 when Dunne Michael W. bought 6,000 shares for $0.37 per share. The transaction valued at 2,191 led to the insider holds 241,001 shares of the business.
Dunne Michael W. bought 15,000 shares of ITRM for $10,854 on Aug 08 ’25. The Director now owns 235,001 shares after completing the transaction at $0.72 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ITRM now has a Market Capitalization of 17479638 and an Enterprise Value of 40047360. For the stock, the TTM Price-to-Sale (P/S) ratio is 44.44. Its current Enterprise Value per Revenue stands at 102.686 whereas that against EBITDA is -2.072.
Stock Price History:
The Beta on a monthly basis for ITRM is 2.96, which has changed by -0.795 over the last 52 weeks, in comparison to a change of 0.19226205 over the same period for the S&P500. Over the past 52 weeks, ITRM has reached a high of $1.85, while it has fallen to a 52-week low of $0.26. The 50-Day Moving Average of the stock is -25.29%, while the 200-Day Moving Average is calculated to be -57.80%.
Shares Statistics:
Over the past 3-months, ITRM traded about 1.04M shares per day on average, while over the past 10 days, ITRM traded about 1441750 shares per day. A total of 52.84M shares are outstanding, with a floating share count of 52.42M. Insiders hold about 0.79% of the company’s shares, while institutions hold 2.55% stake in the company. Shares short for ITRM as of 1767139200 were 1715574 with a Short Ratio of 1.66, compared to 1764288000 on 1644040. Therefore, it implies a Short% of Shares Outstanding of 1715574 and a Short% of Float of 3.2399999999999998.
Earnings Estimates
A comprehensive evaluation of Iterum Therapeutics Plc (ITRM) is underway, with the input of 2.0 analysts contributing to its current rating.The consensus estimate for the next quarter is -$0.1, with high estimates of -$0.1 and low estimates of -$0.1.
Analysts are recommending an EPS of between -$0.59 and -$0.73 for the fiscal current year, implying an average EPS of -$0.66. EPS for the following year is -$0.31, with 2.0 analysts recommending between -$0.24 and -$0.38.
Revenue Estimates
For the next quarter, 2 analysts are estimating revenue of $1.4M. There is a high estimate of $1.4M for the next quarter, whereas the lowest estimate is $1.4M. Based on 2 analysts’ estimates, the company’s revenue will be $9.38M in the next fiscal year. The high estimate is $10M and the low estimate is $8.75M.
